06896.HK
Golden Throat Holdings Group Company Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.28
+0.44%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.2x
Market Cap
HKD 1.68B
MomentumView details →
1D Return
+0.44%
YTD Return
−25.41%
RSI (14)
26.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
1.2x
Market Cap
HKD 1.68B
RSI (14)
26.3
MomentumView details →
1D Return
+0.44%
YTD Return
−25.41%
Similar companies
Latest newsMore news →
Jin Sang Zi (06896.HK) reported interim results for the six months ended June 2026, with revenue of RMB 280 million, down 12.2% year-on-year, and net profit of RMB 47.61 million, down 43.1% year-on-year. No dividend was declared.4d agoJin Sang Zi (06896.HK) issued a profit warning, expecting net profit for the six months ending June to decrease by about 43% year-on-year due to increased sales expenses from expanded promotion.15d ago